Search | Clinical Trials Finder

The live registry is temporarily unavailable. These stored records may be incomplete or out of date. Check the official record for current status and contact information.

ClinicalTrials.gov public records Last synced Nov 4, 2026, 7:33 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1009–1032 of 2,910 matching trials from the local directory fallback.

Filters: Baltimore, Maryland Clear all

Conditions: Glioblastoma (GBM)
Interventions: Music intervention; Other
Lead sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins; Other
Eligibility: 18 Years and older
Enrollment: 35 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2029
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Adult Benign Central Airway Stenosis, Adult Subjects With Symptomatic Benign Airway Obstruction, Adult Tracheobronchial Stenosis, Central Airway Obstruction, Central Airway Stenosis, Tracheal Stenosis
Interventions: Commercial airway balloon dilation, The Airiver Pulmonary drug-coated balloon (DCB) dilation; Device · Combination Product
Lead sponsor: Airiver Medical, Inc.; Industry
Eligibility: 22 Years and older
Enrollment: 200 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2030
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Mid Face Volume Deficit
Interventions: NOA VOLUME, VOLUMA XC; Device
Lead sponsor: AbbVie; Industry
Eligibility: 22 Years and older
Enrollment: 231 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2029
U.S. locations: 15
States / cities: Birmingham, Alabama • Glendale, Arizona • San Diego, California + 11 more

Conditions: Chronic Pain, Musculoskeletal Injury, Orthopaedic Trauma
Interventions: Emotional Awareness and Expression Therapy; Behavioral
Lead sponsor: Johns Hopkins University; Other
Eligibility: 18 Years and older
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2027
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Chronic Pain, Headache
Interventions: Open-label placebo pills; Dietary Supplement
Lead sponsor: University of Maryland, Baltimore; Other
Eligibility: 18 Years to 88 Years
Enrollment: 111 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2028
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Carcinoma, Hepatocellular, Cirrhosis
Interventions: Abbreviated Magnetic Resonance Imaging with serum AFP, Abdominal Ultrasound Screening with serum AFP; Other
Lead sponsor: VA Office of Research and Development; Federal
Eligibility: 18 Years to 75 Years
Enrollment: 4,700 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2031
U.S. locations: 34
States / cities: Birmingham, Alabama • Tucson, Arizona • Little Rock, Arkansas + 31 more

Conditions: AMCI - Amnestic Mild Cognitive Impairment, Sleep Disturbance
Interventions: Placebo, Trazodone; Drug
Lead sponsor: Johns Hopkins University; Other
Eligibility: 55 Years and older
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2028
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: HER2-negative Breast Cancer, Metastatic Breast Cancer
Interventions: CDX-1140, CDX-301, PLD Chemotherapy; Drug
Lead sponsor: University of Texas Southwestern Medical Center; Other
Eligibility: 18 Years to 99 Years
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2029
U.S. locations: 7
States / cities: Chicago, Illinois • Baltimore, Maryland • Chapel Hill, North Carolina + 3 more

Conditions: Diabetic Retinopathy, Hypertension,Essential, Retinal Vascular Disorder, Retinal Vein Occlusion
Interventions: Axial Length Measurement Device, Fundus Imaging, Spectral-Domain (SD) OCT Angiography, Swept-Source (SS) OCT Angiography; Device
Lead sponsor: Johns Hopkins University; Other
Eligibility: 18 Years to 99 Years
Enrollment: 1,050 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2027
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Dementia, Mild Cognitive Impairment (MCI), Potentially Inappropriate Medication Use
Interventions: e-ALIGN Patient-Portal Deprescribing; Other
Lead sponsor: Johns Hopkins University; Other
Eligibility: 65 Years and older
Enrollment: 100 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Colorectal Cancer
Interventions: xBar™ System; Device
Lead sponsor: Exero Medical Ltd.; Industry
Eligibility: 21 Years and older
Enrollment: 80 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 6
States / cities: Louisville, Kentucky • Baltimore, Maryland • Lincoln, Nebraska + 2 more

Conditions: Blood Pressure Disorders, Spinal Cord Injuries
Interventions: ARC-IM System Implantation, ARC-IM Therapy (Group 1), ARC-IM Therapy (Group 2); Procedure · Device
Lead sponsor: ONWARD Medical, Inc.; Industry
Eligibility: 18 Years to 75 Years
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2029
U.S. locations: 12
States / cities: Little Rock, Arkansas • Englewood, Colorado • Miami, Florida + 8 more

Conditions: Chronic Graft-versus-host-disease
Interventions: Axatilimab; Drug
Lead sponsor: Syndax Pharmaceuticals; Industry
Eligibility: 2 Years and older
Enrollment: 296 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2027
U.S. locations: 47
States / cities: Birmingham, Alabama • Duarte, California • Los Angeles, California + 37 more

Conditions: Small Cell Lung Cancer
Interventions: Observation; Other
Lead sponsor: Tempus AI; Industry
Eligibility: 18 Years and older
Enrollment: 200 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2029
U.S. locations: 11
States / cities: Los Alamitos, California • Aurora, Colorado • Peoria, Illinois + 7 more

Conditions: Myelodysplastic Syndromes, Other IDH1-mutated Positive Hematologic Malignancies, Relapsed or Refractory Acute Myeloid Leukemia (AML), Untreated AML
Interventions: AG-120; Drug
Lead sponsor: Institut de Recherches Internationales Servier; Other
Eligibility: 18 Years and older
Enrollment: 291 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2026
U.S. locations: 26
States / cities: Birmingham, Alabama • Phoenix, Arizona • Duarte, California + 21 more

Conditions: Critical Illness, Fasting, Pulmonary Aspiration, Surgical Procedure, Unspecified
Interventions: Fasting, Not fasting; Other
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 18 Years and older
Enrollment: 1,072 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2028
U.S. locations: 19
States / cities: Palo Alto, California • San Francisco, California • Aurora, Colorado + 13 more

Conditions: Cerebellar Ataxia, Cerebellar Diseases, Cerebellar Stroke, Cerebellar Tumor
Interventions: Therapy; Behavioral
Lead sponsor: Hugo W. Moser Research Institute at Kennedy Krieger, Inc.; Other
Eligibility: 18 Years to 75 Years
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2032
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Plasma Cell Myeloma
Interventions: Bortezomib, Daratumumab and Hyaluronidase-fihj, Dexamethasone, Lenalidomide, Quality-of-Life Assessment, Questionnaire Administration; Drug · Other
Lead sponsor: SWOG Cancer Research Network; Network
Eligibility: Not listed
Enrollment: 510 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2031
U.S. locations: 397
States / cities: Anchorage, Alaska • Phoenix, Arizona • Fort Smith, Arkansas + 287 more

Conditions: Multiple Sclerosis, Multiple Sclerosis Fatigue
Interventions: Placebo, Solriamfetol; Drug
Lead sponsor: Johns Hopkins University; Other
Eligibility: 18 Years to 60 Years
Enrollment: 46 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2027
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Breast Feeding, Environmental Exposure, Infant Development
Interventions: Observational only; Other
Lead sponsor: Johns Hopkins Bloomberg School of Public Health; Other
Eligibility: 18 Years and older · Female only
Enrollment: 40 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2027
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Atherosclerosis, Coronary Artery Disease, Coronary Atherosclerosis of Native Coronary Artery
Interventions: PET/CT; Diagnostic Test
Lead sponsor: Johns Hopkins University; Other
Eligibility: 18 Years and older
Enrollment: 33 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2027
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Amputation, Skin Wound, Stem Cell
Interventions: Autologous Skin Fibroblasts, Placebo; Biological
Lead sponsor: Johns Hopkins University; Other
Eligibility: 18 Years to 65 Years
Enrollment: 50 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2028
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Alcohol Use Disorder, Alcoholic Hepatitis
Interventions: Integrated AUD Treatment; Behavioral
Lead sponsor: Johns Hopkins University; Other
Eligibility: 18 Years and older
Enrollment: 200 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2027
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Wounds and Injuries
Interventions: Filler Product, autologous skin fibroblasts; Biological
Lead sponsor: Johns Hopkins University; Other
Eligibility: 18 Years to 65 Years
Enrollment: 80 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2015 – 2028
U.S. locations: 1
States / cities: Baltimore, Maryland

Search by objective public record fields.

Music Therapy in Newly Diagnosed Glioblastoma After Chemoradiation Therapy (MELODY-GBM)

Paclitaxel-Coated Pulmonary Balloon for the Treatment of Benign Central Airway Stenosis

A Study to Evaluate Safety and Effectiveness of NOA VOLUME Injectable Gel in Adult Participants Compared to JUVÉDERM VOLUMA XC for Improvement of Mid-Face Volume

Emotional Awareness and Expression Therapy for People With Persistent Pain Following Orthopedic Trauma

Placebo Impacts Sleep and Pain Modulation in Chronic Pain

Preventing Liver Cancer Mortality Through Imaging With Ultrasound vs. MRI

Targeting Cognition in Early Alzheimer's Disease by Improving Sleep With Trazodone

CD40 Agonist, Flt3 Ligand, and Chemotherapy in HER2 Negative Breast Cancer

Optical Coherence Tomography Angiography in Subjects With Retinal Vascular Disease

e-ALIGN: A Patient Portal-based Intervention to Align Medications With What Matters Most

Anastomotic Safety and Surveillance Using Real-time Enhanced Sensing Using xBar

ARC-IM System to Manage Symptomatic Blood Pressure Instability Secondary to Chronic Spinal Cord Injury

A Study of Axatilimab at 3 Different Doses in Participants With Chronic Graft Versus Host Disease (cGVHD)

Tempus Small Cell Lung Cancer Observational Study (Sculptor)

Study of Orally Administered AG-120 in Subjects With Advanced Hematologic Malignancies With an IDH1 Mutation

Preoperative Fasting vs. Not Fasting in Critically Ill Patients

Individualized Neuro-Modulation Paired With Cerebellar Therapy

Comparing Combinations of Drugs to Treat Newly Diagnosed Multiple Myeloma (NDMM) When a Stem Cell Transplant is Not a Medically Suitable Treatment

Solriamfetol for the Treatment of Multiple Sclerosis Fatigue

Developmental Impacts of Microplastics Exposure in Early Life

PET/CT* vs. Cardiac CT for Detecting Coronary Atherosclerotic Disease [*PET: Positron Emission Tomography; CT: Computed Tomography]

Autologous Volar Fibroblast Injection Into the Stump Site of Amputees

Alcohol Treatment Outcomes Following Early vs. Standard Liver Transplant for SAH

Feasibility Study for Fibroblast Autologous Skin Grafts